Antipodes Partners’s iRhythm Holdings IRTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-655
Closed -$77.3K 141
2026
Q1
$77.3K Buy
655
+466
+247% +$67.2K ﹤0.01% 98
2025
Q4
$33.5K Sell
189
-31
-14% -$5.49K ﹤0.01% 115
2025
Q3
$37.8K Sell
220
-35
-14% -$5.56K ﹤0.01% 100
2025
Q2
$39.3K Buy
+255
New +$33K ﹤0.01% 91

Other funds holding IRTC

Antipodes Partners's IRTC Position: Q2 2026 in Review

Antipodes Partners sold out of iRhythm Holdings (IRTC) in Q2 2026, closing a stake of 655 shares — an estimated $77.3K sold.

Antipodes Partners first reported a position in IRTC in Q2 2025 and held it in 4 quarters. The position peaked at $77.3K in Q1 2026. 304 funds tracked by Wall St. Rank hold IRTC as of Q2 2026.

  • Antipodes Partners reported no remaining iRhythm Holdings position as of Q2 2026 after selling out during the quarter.
  • Antipodes Partners sold 655 iRhythm Holdings shares in Q2 2026, an estimated $77.3K.
  • Antipodes Partners first reported a position in iRhythm Holdings in Q2 2025 and held it in 4 quarters.
  • Antipodes Partners's iRhythm Holdings position peaked at $77.3K in Q1 2026.
  • 304 funds tracked by Wall St. Rank held iRhythm Holdings as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.